drugset / Trial / NCT04726592
Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of clorazepate in addition to the usual medication for treating migraine attack in the emergency room
Timeline
- Start
- 2021-07-08
- Primary completion
- 2024-04-10
- Completion
- 2024-04-10
Outcome
Outcome not reported
Stopped (Enrollment): “It has been determined that continuing with enrollments in this study is no longer justified due to the lack of significant impact on the expected outcomes.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clorazepate | Small molecule | 20 mg | Intravenous |
| Background | Ketoprofen | Small molecule | 100 mg | Intravenous |
| Background | Metoclopramide | Small molecule | 10 mg | Intravenous |